Robert T. Perri
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Genetics 7
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Neil E. Kay (8 shared papers)Martin M. Oken (6 shared papers)John R. Hoidal (1 shared paper)Richard B. Fox (1 shared paper)John E. Repine (1 shared paper)John I. Allen (3 shared papers)Robert P. Hebbel (1 shared paper)Craig J. McClain (2 shared papers)
- Journals
- American Journal of Hematology (3 papers)Journal of Clinical Oncology (1 paper)BMC Cell Biology (1 paper)Therapeutic Drug Monitoring (1 paper)Annals of Emergency Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Robert T. Perri
21 papers receiving 609 citations
Peers
Comparison fields: 5 of 81
- Hematology 157
- Genetics 96
- Nutrition and Dietetics 128
- Immunology 137
- Oncology 120
Countries citing papers authored by Robert T. Perri
This map shows the geographic impact of Robert T. Perri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Perri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Perri more than expected).
Fields of papers citing papers by Robert T. Perri
This network shows the impact of papers produced by Robert T. Perri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Perri. The network helps show where Robert T. Perri may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert T. Perri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 178 | |
| 2 | Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. | 1983 | 125 |
| 3 | 1981 | 97 | |
| 4 | Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas. | 1992 | 73 |
| 5 | Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma. | 1982 | 27 |
| 6 | 1986 | 20 | |
| 7 | 1983 | 20 | |
| 8 | 1985 | 17 | |
| 9 | 1984 | 16 | |
| 10 | Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity. | 1985 | 13 |
| 11 | 1988 | 12 | |
| 12 | 1986 | 9 | |
| 13 | 1998 | 8 | |
| 14 | 2009 | 7 | |
| 15 | 1982 | 7 | |
| 16 | 1989 | 6 | |
| 17 | 1987 | 6 | |
| 18 | Zinc - In vitro and in vivo demonstration of its role in modulating human lymphocyte and monocyte tumor cell interaction | 1982 | 2 |
| 19 | 2001 | 2 | |
| 20 | 1985 | 1 |
About Robert T. Perri
Robert T. Perri is a scholar working on Molecular Biology, Genetics, Pathology and Forensic Medicine, Hematology and Immunology, having authored 22 papers that have together received 647 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Multiple Myeloma Research and Treatments (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Trace Elements in Health (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (157 citations), Genetics (96 citations), Nutrition and Dietetics (128 citations), Immunology (137 citations) and Oncology (120 citations). Robert T. Perri has collaborated with scholars based in United States. Frequent co-authors include Neil E. Kay, Martin M. Oken, John R. Hoidal, Richard B. Fox, John E. Repine, John I. Allen, Robert P. Hebbel, Craig J. McClain, K Gajl-Peczalska and G A Niehans. Their work appears in journals such as American Journal of Hematology, Journal of Clinical Oncology, BMC Cell Biology, Therapeutic Drug Monitoring and Annals of Emergency Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.